Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Lucas

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Current Cancer Drug Targets|September 24, 2005
Tumor necrosis factor: how to make a killer molecule tumor-specific?Rudolf Lucas, Matthias Kresse, Markus Latta, et al.
Pharmaceutical Research|September 23, 2010
Application of alpha7 nicotinic acetylcholine receptor agonists in inflammatory diseases: an overviewMario B Marrero, Merouane Bencherif, Patrick M Lippiello, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2007
ATP-depleting carbohydrates prevent tumor necrosis factor receptor 1-dependent apoptotic and necrotic liver injury in miceMarkus Latta, Gerald Künstle, Rudolf Lucas, et al.
Cellular and Molecular Life Sciences : CMLS|October 19, 2010
Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseasesMerouane Bencherif, Patrick M Lippiello, Rudolf Lucas, et al.
Frontiers in Immunology|June 16, 2023
Editorial: Insights in inflammation: 2022Pietro Ghezzi, Rudolf Lucas, Simone Mader, et al.
Lung|February 10, 2009
Ebselen improves ischemia-reperfusion injury after rat lung transplantationJürg Hamacher, Uz Stammberger, Elvira Weber, et al.
Journal of Cardiovascular Disease Research|July 1, 2011
P2Y receptors as regulators of lung endothelial barrier integrityEvgeny Zemskov, Rudolf Lucas, Alexander D Verin, et al.
Toxicology Letters|March 12, 2003
Redox control of hepatic cell deathHannes Hentze, Markus Latta, Gerald Künstle, et al.
Toxicology|August 7, 2004
Toxicity of nutritionally available selenium compounds in primary and transformed hepatocytesMarkus Weiller, Markus Latta, Matthias Kresse, et al.
Frontiers in Immunology|December 3, 2014
Arginase in the vascular endothelium: friend or foe?Rudolf Lucas, David Fulton, Robert William Caldwell, et al.
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Current Cancer Drug Targets|September 24, 2005
Tumor necrosis factor: how to make a killer molecule tumor-specific?Rudolf Lucas, Matthias Kresse, Markus Latta, et al.
Pharmaceutical Research|September 23, 2010
Application of alpha7 nicotinic acetylcholine receptor agonists in inflammatory diseases: an overviewMario B Marrero, Merouane Bencherif, Patrick M Lippiello, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2007
ATP-depleting carbohydrates prevent tumor necrosis factor receptor 1-dependent apoptotic and necrotic liver injury in miceMarkus Latta, Gerald Künstle, Rudolf Lucas, et al.
Cellular and Molecular Life Sciences : CMLS|October 19, 2010
Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseasesMerouane Bencherif, Patrick M Lippiello, Rudolf Lucas, et al.
Frontiers in Immunology|June 16, 2023
Editorial: Insights in inflammation: 2022Pietro Ghezzi, Rudolf Lucas, Simone Mader, et al.
Lung|February 10, 2009
Ebselen improves ischemia-reperfusion injury after rat lung transplantationJürg Hamacher, Uz Stammberger, Elvira Weber, et al.
Journal of Cardiovascular Disease Research|July 1, 2011
P2Y receptors as regulators of lung endothelial barrier integrityEvgeny Zemskov, Rudolf Lucas, Alexander D Verin, et al.
Toxicology Letters|March 12, 2003
Redox control of hepatic cell deathHannes Hentze, Markus Latta, Gerald Künstle, et al.
Toxicology|August 7, 2004
Toxicity of nutritionally available selenium compounds in primary and transformed hepatocytesMarkus Weiller, Markus Latta, Matthias Kresse, et al.
Frontiers in Immunology|December 3, 2014
Arginase in the vascular endothelium: friend or foe?Rudolf Lucas, David Fulton, Robert William Caldwell, et al.
Pageof 13